Hold with 10-15% trim and tightened $240 trailing stop; preserve core exposure to structural bull case
The 10-15% trim honors the 9/4 reflection (must trim when deferring adds in extension-plus-divergence) while the 9/1 reflection (25-35% trim is over-calibrated) argues against over-reduction. Maintaining ~85% exposure preserves asymmetric participation in the AI re-rating thesis at 15.56x forward earnings while the $240.19 VWMA stop provides tighter risk architecture than the $200 hard backstop. The $250 December put collar caps tail risk at ~1% of position cost. Deferring fresh capital at $249.12 without trimming would replicate the -3.4% alpha loss from 9/4.
| Position | Action |
|---|---|
| ~85% of current position | Maintain core CRM exposure to preserve participation in fundamental bull thesis (Agentforce monetization, $14.4B FCF, 21.5% operating margins) |
| 10-15% trim at $248-251 | Execute limit orders to capture partial post-rally gains; deploy proceeds as dry powder for reload zones |
CRM is a high-quality compounder with reaccelerating revenue growth, strong cash generation, and a diversified enterprise platform trading at 15.56x forward earnings—buy/accumulate for long-term investors despite near-term overbought conditions.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | $200.16 | bullish |
| close_50_sma | $193.47 | bullish |
| close_10_ema | $245.74 | bullish |
| rsi | 67.55 | neutral |
| macd | 19.75 | neutral |
| macdh | 2.75 | bearish |
| boll_ub | $280.18 | neutral |
| vwma | $240.19 | bullish |
Support: 245.74 · 240.19 · 230 · 223.5 · 193.47 | Resistance: 264.43 · 280.18
The 8/27 breakout initiated a major trend reversal, with CRM holding above all key moving averages (10-EMA $245.74, 50-SMA $193.47, 200-SMA $200.16). A golden cross is forming as the 50-SMA rises ~$2/day toward the descending 200-SMA, likely completing within 2–3 weeks. Momentum is the primary concern: the MACD histogram peaked at 5.72 on 9/1 and has declined for five consecutive sessions to 2.75, while RSI has cooled from 81.89 (overbought) to 67.55. Key support lies at the 10-EMA ($245.74) and VWMA ($240.19), with the 8/27 gap-fill zone at $230 as a potential re-entry magnet. The pullback to $249.12 on 15.3M shares (vs. 55.5M on 8/27) represents healthy digestion rather than distribution.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Gap-fill scenario into $205-215: fills 8/27 breakout gap, retests rising 200-SMA near $200, forward P/E in 13-14x range, FCF yield approaching 9%
Then: Evaluate re-entry as golden cross becomes probable and multiple compression creates asymmetric setup
AI is not destroying SaaS; CRM's distribution, data advantages, and integrated platform create enterprise moat
EV: $272–$288 · concedes: Bear is correct that CRM is not a low-risk entry after 34-40% one-month rally and RSI above 80; Do not recommend chasing with oversized position; MACD histogram decline signals momentum slowing—be disciplined; MACD histogram has declined from 5.72 to 2.75; Fully confirmed golden cross has not yet occurred (50-day SMA still below 200-day SMA); Bear correctly raises concerns about Informatica acquisition, goodwill ($57.941 billion, 51.6% of assets), and debt; Tangible book value is negative; Earnings were inflated by $1.51 billion securities gain; adjusted EPS closer to $6.60; Short-term trader can reasonably choose HOLD; 93% probability of no Fed cuts is genuine valuation headwind
CRM is a coiled spring for disappointment, not a buy-the-dip opportunity — the price of admission has gotten dangerously high relative to actual risk-reward given fading chart momentum, AI disruption headwinds, macro compression risk, overstated earnings quality, and an Informatica integration overhang that will pressure margins through FY2028.
EV: -20% to -30% on disappointment; +10% to +15% on perfection · concedes: CRM is a high-quality compounder with strong cash flow; Forward P/E of 15.56x appears reasonable on surface; Operating margin expansion from FY2023 to FY2026 is a real achievement; Stage entry plan at $245–$250 acknowledges some risk, though bear argues this is still too high; Net debt/EBITDA of 0.55x looks comfortable on reported figures; The right entry at $200–215 (filling the 8/27 gap and testing 200-day SMA at ~13–14x forward P/E) would be a 'reasonable' multiple per bull's own definition
Market Cap
$205.03 B
TTM EPS
$10.91
Forward EPS
$16.01
Trailing P/E
22.83x
Forward P/E
15.56x
PEG Ratio
1.05
Price/Book
5.34x
Dividend Yield
0.68%
Beta
1.20
52-Week High
$269.11
52-Week Low
$146.32
50-Day MA
$191.65
200-Day MA
$200.75
Revenue FY2026
$41,525 M
Revenue Growth FY2025
8.7%
Gross Margin FY2026
77.7%
Operating Income FY2026
$8,917 M
Net Income FY2026
$7,457 M
Diluted EPS FY2026
$7.80
Operating Cash Flow FY2026
$14,996 M
Free Cash Flow FY2026
$14,402 M
FCF Margin TTM
40.4%
Cash & ST Investments
$9,565 M
Goodwill
$57,941 M
Total Debt
$17,176 M
Net Debt
$7,112 M
Net Debt FY2025
($93 M)
Working Capital FY2026
($8,896 M)
Current Ratio
0.84
Tangible Book Value
($5.6 B)
Gross Margin TTM
77.3%
Operating Margin TTM
21.4%
Net Margin TTM
22.0%
EBITDA Margin TTM
29.4%
Return on Equity TTM
19.4%
Return on Assets TTM
5.7%
Share Repurchases FY2026
$12,596 M
Dividends Paid FY2026
$1,587 M
Acquisitions FY2026
$9,268 M
Net Debt Issuance FY2026
$5,416 M
Revenue FY2023
$31,352 M
Net Income FY2023
$208 M
Operating Margin FY2023
3.3%
FCF FY2023
$6,313 M
R&D as % Revenue FY2026
14.4%
S&M as % Revenue FY2026
32.1%
FCF Yield
~7.0%
EV/EBITDA (est.)
~16.7x
Net Income 3-Year Growth
36x
Goodwill / Total Assets
51.6%
Strengths
Concerns
HOLD
Macro: Fed path: 93% NO cuts in 2026 (Polymarket, $8.16M volume, +3.9pp/wk). Recession odds: U.S. 8% ($1.74M volume), UK 8%, Japan 7%. Geopolitical risk: Middle East hostilities lifting oil, U.S.–Canada trade tensions. FRED data (CPI, Fed funds, 10y, unemployment, VIX) unavailable — flagged for independent verification.